Celldex Therapeutics, Inc. 4
4 · Celldex Therapeutics, Inc. · Filed Jun 9, 2016
Insider Transaction Report
Form 4
Davis Thomas Andrew
Sr. VP & CMO
Transactions
- Award
Incentive Stock Option
2016-06-08+157,000→ 157,000 totalExercise: $4.72From: 2017-06-08Exp: 2026-06-08→ Common Stock (157,000 underlying)
Footnotes (1)
- [F1]25% vest on June 8, 2017 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.